Skip to main content
Yingchi Zhang on Muck Rack

Yingchi Zhang

As seen in: Nature, Wiley Online Library, MDPI, Taylor & Francis Online
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingchi

Contact Yingchi, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effects of deformation temperature and strain rate on hot deformation behaviour and optimisation of processing maps of SWRH82B high-carbon steel

|
By Yingchi Zhang, Jing Guo, Zihao Tang
| Taylor & Francis Online
ABSTRACT Isothermal hot compression tests were performed on surface and centre specimens cut from SWRH82B high-carbon steel continuously cast billets at 950–1100 °C and 0.01–7 s−¹. Arrhenius-type constitutive equations and hot processing maps based on the Dynamic Materials Model were developed to characterise and optimise hot working behaviour. Results reveal that flow stress decreases with increasing temperature and rises with higher strain rate for both regions.
Open in Who Shared Issue with article?

Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy - Nature Biomedical Engineering

|
By Fangxiao Hu, Jianhuan Li, Yao Wang, Yunqing Lin, Jingliao Zhang, Jiacheng Xu, Xiujuan Zheng, Qitong Weng, Xiaofei Liu, Yang Geng, Hongling Wu, Lijuan Liu, Huan Peng, Bingyan Wu, Dehao Huang, Chengxiang Xia, Tongjie Wang, Xin Du, Hui Zeng, Fang Dong, Yingchi Zhang, Xiaofan Zhu, Mengyun Zhang
| Nature Verified
Abstract Chimaeric antigen receptor (CAR) natural killer (CAR-NK) cells are a promising alternative to CAR-T cells for immunotherapies. High and multiple doses of CAR-NK cell infusions are essential to maintain therapeutic efficacy in clinical trials, requiring efficient methods for generating CAR-NK cells at scale.
Open in Who Shared Issue with article?

Risk of COVID‐19 infection and seizure exacerbation among patients with epilepsy during the peak of Omicron wave

|
By Xiuxiu Leng, Gengyao Hu, Xuan Wang, Yingchi Zhang
| Wiley Online Library Verified
53.2% of patients with epilepsy (PWE) were infected with COVID-19, similar to general population. 16.4% of PWE developed seizure exacerbation after COVID-19 infection. PWE with active epilepsy were at higher risk of COVID-19 infection and seizure exacerbation.
Open in Who Shared Issue with article?
See all 5 articles